膀胱癌术后吉西他滨膀胱灌注及术后护理的研究进展

Research progress in gemcitabine intravesical perfusion and postoperative care after bladder cancer surgery

膀胱肿瘤是泌尿系统的常见肿瘤之一,在我国发病率和死亡率均占泌尿系肿瘤的首位,且术后肿瘤的复发率也较高。近些年临床中开始在膀胱癌术后膀胱灌注吉西他滨。主要总结了膀胱癌术后灌注常用药物及、灌注方法、灌注时间及治疗时间,以及吉西他滨的优势和药物配置,并讨论了膀胱灌注过程中的有关护理及相关并发症的处理。

Bladder tumors are one of the most common tumors of the urinary system,accounting for the highest morbidity and mortality rates of urological tumors in China,and the recurrence rate of postoperative tumors is also high.In recent years,bladder instillation of gemcitabine after bladder cancer surgery has been started in clinical practice.In this review,the dose,infusion method,and treatment time of commonly used bladder infusions of gemcitabine were summarized,the advantages of gemcitabine for postoperative bladder infusion in bladder cancer were reviewed,and the care related to the process of bladder infusion and the management of related complications were discussed.